Evidence map›Paper›PMID 29161659›Full record

ArticleInternational immunopharmacology2018

Lipopolysaccharide (LPS)-mediated priming of toll-like receptor 4 enhances oxidant-induced prostaglandin E

Yan Zhang, Orisa J Igwe

Open access · greenAbstract read
In one paragraph

Article in International immunopharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Immunomodulatory Effects and Regulatory Mechanisms of (Journal of agricultural and food chemistry · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Yan ZhangUniversity of Missouri-Kansas City, School of Pharmacy, Division of Pharmacology & Toxicology, 2464 Charlotte Street, Kansas City, Missouri 64108, USA. Electronic address: yzqh9@mail.umkc.edu.
Orisa J IgweUniversity of Missouri-Kansas City, School of Pharmacy, Division of Pharmacology & Toxicology, 2464 Charlotte Street, Kansas City, Missouri 64108, USA. Electronic address: igweo@umkc.edu.
University of Missouri–Kansas City · US

Funding

TOLL-LIKE RECEPTOR IN PROOXIDANT MODEL OF OROFACIAL PAINR15DE021888 · NIDCR · UNIVERSITY OF MISSOURI KANSAS CITY · PI IGWE, ORISA JOHN · 2011 to 2011
$439k
NIDCR NIH HHS R15 DE021888
6 · The paper itself

Abstract

Agonists and pseudo-agonists for toll-like receptor 4 (TLR4) are common in our environment. Thus, human exposure to these agents may result in "priming or sensitization" of TLR4. A body of evidence suggests that LPS-mediated sensitization of TLR4 can increase the magnitude of responses to exogenous agents in multiple tissues. We have previously shown that reactive oxygen and nitrogen species (RONS) stimulate TLR4. There is no evidence that LPS-primed TLR4 can influence the magnitude of responses to oxidants from either endogenous or exogenous sources. In the present study, we directly tested the hypothesis that LPS-primed TLR4 will sensitize primary murine peritoneal macrophages (pM) to oxidant-mediated prostaglandin E2 (PGE

Indexed as

AnimalsCells, CulturedChromatesDinoprostoneImmunizationLipopolysaccharidesMacrophages, PeritonealMiceMice, Inbred C57BLMice, KnockoutOxidantsPeroxidesPrimary Cell CultureReactive Nitrogen SpeciesReactive Oxygen SpeciesToll-Like Receptor 4ChromatesDinoprostoneLipopolysaccharidesOxidantsPeroxidespotassium tetraperoxochromateReactive Nitrogen SpeciesReactive Oxygen SpeciesTlr4 protein, mouseToll-Like Receptor 4CyclooxygenasesOxidative stressPhospholipase A2Primary murine macrophagesToll-like receptor 4

Identifiers

PMID29161659
PMCPMC5732025
OpenAlexW2768728780

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.